The case for & against
Bull & Bear analysis
Bearish
Gyrodyne, LLC (NASDAQ: GYRO) is a New York-based limited liability company that is involved in the ownership and management of a diverse portfolio of real estate properties, primarily focused on office, industrial, and service-oriented buildings in the New York metropolitan area. The company is currently undergoing a liquidation process with plans to sell its properties in an orderly manner, utilizing its approximately 87-acre campus in Stony Brook and a medical office park in Cortlandt Manor, to maximize the value extraction from these assets.
Bull says
- ↑Share price $6.23 vs $11.79 liquidation estimate; Book/Price 0.95.
- ↑87-acre Stony Brook campus and medical office park support NAV.
- ↑0.93% dividend yield preserves income during wind-down.
- ↑Low leverage factor shows minimal debt burden.
- ↑Positive MACD and pivot buy signal hint at momentum shift.
- ↑Strong growth factor and QS score suggest undervaluation.
Bear says
- ↓Stock fell 5.76% in June; Volatility score indicates erratic swings.
- ↓Earnings Yield at –1.17 and Profitability at –0.06 signal weak returns.
- ↓Rising rates and CRE slowdown may reduce liquidation proceeds.
- ↓Insider selling raises governance and confidence concerns.
- ↓Liquidity constraints could delay or devalue property sales.
- ↓Remote-work trend risks future demand for office assets.